Paclitaxel poliglumex for ovarian cancer

A phase II study of paclitaxel poliglumex in combination with transdermal estradiol for the treatment of metastatic castration-resistant prostate cancer after docetaxel chemotherapy

(2010) Tomasz M. Beer et al.   ANTI-CANCER DRUGS

Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse

(2010) Eric Pujade-Lauraine et al.   JOURNAL OF CLINICAL ONCOLOGY

Perception of alopecia by patients requiring chemotherapy for non-small-cell lung cancer: A willingness to pay study

(2010) Mélisande Bernard et al.   LUNG CANCER

Assessment of factors that contribute to decreased quality of life in Gynecologic Oncology Group ovarian cancer trials

(2009) Vivian E. von Gruenigen et al.   CANCER

Impact on survival of 12 versus 3 monthly cycles of paclitaxel (175 mg/m2) administered to patients with advanced ovarian cancer who attained a complete response to primary platinum-paclitaxel: Follow-up of a Southwest Oncology Group and Gynecologic Oncology Group phase 3 trial

(2009) Maurie Markman et al.   GYNECOLOGIC ONCOLOGY

Phase III Trial Comparing Paclitaxel Poliglumex (CT-2103, PPX) in Combination with Carboplatin Versus Standard Paclitaxel and Carboplatin in the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer

(2009) Corey J. Langer et al.   Journal of Thoracic Oncology

Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer

(2008) L Paz-Ares et al.   BRITISH JOURNAL OF CANCER

Phase I study of paclitaxel poliglumex administered weekly for patients with advanced solid malignancies

(2008) Monica Mita et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Paclitaxel poliglumex and carboplatin as first-line therapy in ovarian, peritoneal or fallopian tube cancer: A phase I and feasibility trial of the Gynecologic Oncology Group

(2008) Mark A. Morgan et al.   GYNECOLOGIC ONCOLOGY

A phase II trial of paclitaxel poliglumex in recurrent or persistent ovarian or primary peritoneal cancer (EOC): A gynecologic oncology group study

(2008) Paul Sabbatini et al.   GYNECOLOGIC ONCOLOGY